NeuroSense Therapeutics Ltd. closed fiscal year 2025 with $1.0M in total assets, $2.6M in total liabilities and -$1.6M in shareholder equity. Total assets fell 77.5% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters NeuroSense Therapeutics Ltd. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NRSN Balance Sheet by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
NRSN Balance Sheet by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More NeuroSense Therapeutics Ltd. financials
Frequently Asked Questions
NeuroSense Therapeutics Ltd. closed fiscal year 2025 with $1.0M in total assets, $2.6M in total liabilities and -$1.6M in shareholder equity.
NeuroSense Therapeutics Ltd. (NRSN) total assets fell by 77.5% year over year, from $4.6M to $1.0M in fiscal year 2025.
NeuroSense Therapeutics Ltd. (NRSN) reported $1.0M in total assets in Q4 2025. This represents a decrease of 77.5% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what NeuroSense Therapeutics Ltd. (NRSN) reported on that line in every period on record.